What's New in Musculoskeletal Infection
- PMID: 38781349
- DOI: 10.2106/JBJS.24.00230
What's New in Musculoskeletal Infection
Conflict of interest statement
Disclosure: The Disclosure of Potential Conflicts of Interest forms are provided with the online version of the article ( http://links.lww.com/JBJS/I31 ).
References
-
- Wixted CM, Charalambous LT, Kim BI, Cochrane NH, Belay ES, Joseph HL, Seyler TM. Direct costs vary by outcome in two-stage revision arthroplasty for the treatment of hip periprosthetic joint infection. Arthroplast Today. 2022 Nov 28;19:101061.
-
- Charalambous LT, Wixted CM, Kim BI, Cochrane NH, Belay ES, Joseph HL, Seyler TM. Cost drivers in two-stage treatment of hip periprosthetic joint infection with an antibiotic coated cement hip spacer. J Arthroplasty. 2023 Jan;38(1):6-12.
-
- Shichman I, Sobba W, Beaton G, Polisetty T, Nguyen HB, Dipane MV, Hayes E, Aggarwal VK, Sassoon AA, Chen AF, Garceau SP, Schwarzkopf R. The effect of prosthetic joint infection on work status and quality of life: a multicenter, international study. J Arthroplasty. 2023 Dec;38(12):2685-2690.e1.
-
- Das A, Agarwal AR, Gu A, Stake S, Bernstein SA, Golladay GJ, Thakkar SC. Higher 2-year cumulative incidence of mental health disorders following antibiotic spacer placement for chronic periprosthetic joint infection following total joint arthroplasty. J Arthroplasty. 2023 Jul;38(7):1349-1355.e1.
-
- Harmer JR, Wyles CC, Duong SQ, Morgan Iii RJ, Maradit-Kremers H, Abdel MP. Depression and anxiety are associated with an increased risk of infection, revision, and reoperation following total hip or knee arthroplasty. Bone Joint J. 2023 May 1;105-B(5):526-33.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources